| Issue Date | Title | Author(s) |
| 2014-04-01 | Copper pathology in vulnerable brain regions in Parkinson's disease | Davies, KM; Bohic, S; Carmona, A; Ortega, R; Cottam, V; Hare, DJ; Finberg, JPM; Reyes, S; Halliday, GM; Mercer, JFB; Double, KL |
| 2017-03-01 | Glutathione peroxidase 4: A new player in neurodegeneration? | Cardoso, BR; Hare, DJ; Bush, AI; Roberts, BR |
| 2016-11-14 | Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid | Roberts, BR; Doecke, JD; Rembach, A; Yévenes, LF; Fowler, CJ; McLean, CA; Lind, M; Volitakis, I; Masters, CL; Bush, AI; Hare, DJ |
| 2009-01 | Thin films of Ruthenium Phthalocyanine complexes | Rawling, T; Austin, CE; Hare, DJ; Doble, PA; Zareie, HM; McDonagh, AM |
| 2019-01-01 | Simultaneous nanostructure and chemical imaging of intact whole nematodes | Jones, MWM; Phillips, NW; Abbey, B; Hare, DJ; Van Riessen, GA; Vine, DJ; De Jonge, MD; McColl, G |
| 2021-09-29 | Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. | Finkelstein, DI; Billings, JL; Adlard, PA; Ayton, S; Sedjahtera, A; Masters, CL; Wilkins, S; Shackleford, DM; Charman, SA; Bal, W; Zawisza, IA; Kurowska, E; Gundlach, AL; Ma, S; Bush, AI; Hare, DJ; Doble, PA; Crawford, S; Gautier, ECL; Parsons, J; Huggins, P; Barnham, KJ; Cherny, RA |
| 2022-06 | Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy. | Alves, FM; Kysenius, K; Caldow, MK; Hardee, JP; Chung, JD; Trieu, J; Hare, DJ; Crouch, PJ; Ayton, S; Bush, AI; Lynch, GS; Koopman, R |
| 2021-03 | Correction to: Sex‑dependent association between selenium status and cognitive performance in older adults. | Cardoso, BR; Hare, DJ; Macpherson, H |
| 2022-09-14 | Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord. | Trist, BG; Genoud, S; Roudeau, S; Rookyard, A; Abdeen, A; Cottam, V; Hare, DJ; White, M; Altvater, J; Fifita, JA; Hogan, A; Grima, N; Blair, IP; Kysenius, K; Crouch, PJ; Carmona, A; Rufin, Y; Claverol, S; Van Malderen, S; Falkenberg, G; Paterson, DJ; Smith, B; Troakes, C; Vance, C; Shaw, CE; Al-Sarraj, S; Cordwell, S; Halliday, G; Ortega, R; Double, KL |
| 2019-07-01 | l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease | Billings, JL; Gordon, SL; Rawling, T; Doble, PA; Bush, AI; Adlard, PA; Finkelstein, DI; Hare, DJ |
